Correlation Between Chia and XSpray Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chia and XSpray Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chia and XSpray Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chia and XSpray Pharma AB, you can compare the effects of market volatilities on Chia and XSpray Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chia with a short position of XSpray Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chia and XSpray Pharma.

Diversification Opportunities for Chia and XSpray Pharma

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Chia and XSpray is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Chia and XSpray Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XSpray Pharma AB and Chia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chia are associated (or correlated) with XSpray Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XSpray Pharma AB has no effect on the direction of Chia i.e., Chia and XSpray Pharma go up and down completely randomly.

Pair Corralation between Chia and XSpray Pharma

Assuming the 90 days trading horizon Chia is expected to generate 1.01 times more return on investment than XSpray Pharma. However, Chia is 1.01 times more volatile than XSpray Pharma AB. It trades about -0.03 of its potential returns per unit of risk. XSpray Pharma AB is currently generating about -0.14 per unit of risk. If you would invest  2,127  in Chia on October 26, 2024 and sell it today you would lose (181.00) from holding Chia or give up 8.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy80.95%
ValuesDaily Returns

Chia  vs.  XSpray Pharma AB

 Performance 
       Timeline  
Chia 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Chia are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical indicators, Chia exhibited solid returns over the last few months and may actually be approaching a breakup point.
XSpray Pharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XSpray Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Chia and XSpray Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chia and XSpray Pharma

The main advantage of trading using opposite Chia and XSpray Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chia position performs unexpectedly, XSpray Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XSpray Pharma will offset losses from the drop in XSpray Pharma's long position.
The idea behind Chia and XSpray Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance